D8132
脱氢- L -(+)-抗坏血酸二聚体
≥80% (enzymatic)
别名:
DHA, 双羟萘酸, 双（脱氢- L -抗坏血酸）
登录 查看组织和合同定价。
选择尺寸
关于此项目
经验公式（希尔记法）:
C12H12O12
化学文摘社编号:
分子量:
348.22
UNSPSC Code:
12352205
PubChem Substance ID:
NACRES:
NA.79
Beilstein/REAXYS Number:
84277
MDL number:
产品名称
脱氢- L -(+)-抗坏血酸二聚体, ≥80% (enzymatic)
SMILES string
O1[C@@H](C(=O)C(=O)C1=O)[C@@H](O)CO
InChI
1S/C6H6O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h2,5,7-8H,1H2/t2-,5+/m0/s1
InChI key
SBJKKFFYIZUCET-JLAZNSOCSA-N
biological source
synthetic
assay
≥80% (enzymatic)
form
powder
color
faint beige to beige
faint brown to light brown
white to yellow
shipped in
dry ice
storage temp.
−20°C
Quality Level
正在寻找类似产品? 访问 产品对比指南
Other Notes
晶型二聚体；水合单体水溶液
Application
脱氢-L-(+)-抗坏血酸二聚体已被用于研究其在pH、浓度和温度影响下的转化和稳定性。
Biochem/physiol Actions
脱氢-L-(+)-抗坏血酸二聚体用于使抗坏血酸 (AA) 再生。AA氧化为脱氢抗坏血酸 (DHA) 是在细胞外液和细胞中发生的。AA可作为抗氧化剂和酶的辅助因子。它已被广泛用于各种应用，包括细胞培养。它也是有助于减少氧化应激的还原剂。L-抗坏血酸可通过生物系统由脱氢抗坏血酸（DHA）再生。
General description
脱氢-L-(+)-抗坏血酸二聚体是一种水溶性分子，由维生素C在胃肠道腔产生。
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Gisele Monteiro et al.
Proceedings of the National Academy of Sciences of the United States of America, 104(12), 4886-4891 (2007-03-16)
Peroxiredoxins (Prx) are widely distributed peroxidases that can be divided into 1-Cys and 2-Cys Prx groups based on the number of conserved cysteine residues that participate in their catalytical cycle. Prx have been described to be strictly dependent on thiols
Vitamin C (2017)
The physiological role of dehydroascorbic acid
Wilson JX
Febs Letters, 527(1-3), 5-9 (2002)
Sarah E Bohndiek et al.
Journal of the American Chemical Society, 133(30), 11795-11801 (2011-06-23)
Dynamic nuclear polarization (DNP) of (13)C-labeled metabolic substrates in vitro and their subsequent intravenous administration allow both the location of the hyperpolarized substrate and the dynamics of its subsequent conversion into other metabolic products to be detected in vivo. We
A Wesley Burks et al.
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 26(4), 316-322 (2015-04-08)
Children with cow's milk allergy (CMA) are at risk for inadequate nutritional intake and growth. Dietary management of CMA, therefore, requires diets that are not only hypoallergenic but also support adequate growth in this population. This study assessed growth of
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持